pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

28,941 catalysts · 9,438 approval · 5,000 device 510k · 4,728 grant · 2,984 8k filing · 2,000 device pma · 2,000 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 0 catalysts2026-08-07: 34 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 11 catalysts2026-08-11: 9 catalysts2026-08-12: 13 catalysts2026-08-13: 12 catalysts2026-08-14: 3 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 1 catalyst2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 1 catalyst2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 10 catalysts2026-10-29: 17 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2017-11-21×clear all
type
  • approval9,438
  • device 510k5,000
  • grant4,728
  • 8k filing2,984
  • device pma2,000
  • device recall2,000
recall
1,126
  • device adverse event1,000
  • earnings508
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Oct 19, 2020

    15
    ›Oct 19, 2020approval2119d agoARIKAYCE KIT (AMIKACIN SULFATE) — FDA approvalamikacin sulfate PR

    Sponsor: INSMED INC. Form: SUSPENSION, LIPOSOMAL. Route: INHALATION

    full page →amikacin sulfate PR →fda approvals ↗
    ›Oct 19, 2020approval2119d agoRISPERIDONE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Oct 19, 2020approval2119d agoRISPERIDONE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Oct 19, 2020approval2119d agoRISPERIDONE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Oct 19, 2020approval2119d agoRISPERIDONE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Oct 19, 2020approval2119d agoRISPERIDONE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Oct 20, 2020approval2118d agoSABRIL (VIGABATRIN) — FDA approvalVIGABATRIN

    Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL

    full page →VIGABATRIN →fda approvals ↗
    ›Oct 20, 2020approval2118d agoWELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Oct 20, 2020approval2118d agoWELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Oct 21, 2020approval2117d agoOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

    Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

    full page →dexamethasone LA →fda approvals ↗
    ›Oct 22, 2020approval2116d agoSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvaltedizolid phosphate

    Sponsor: CUBIST PHARMS LLC. Form: TABLET. Route: ORAL

    full page →tedizolid phosphate →fda approvals ↗
    ›Oct 22, 2020approval2116d agoSIVEXTRO (TEDIZOLID PHOSPHATE) — FDA approvaltedizolid phosphate

    Sponsor: CUBIST PHARMS LLC. Form: POWDER. Route: INTRAVENOUS

    full page →tedizolid phosphate →fda approvals ↗
    ›Oct 22, 2020approval2116d agoCOMETRIQ (CABOZANTINIB S-MALATE) — FDA approvalcabozantinib s-malate

    Sponsor: EXELIXIS. Form: CAPSULE. Route: ORAL

    full page →cabozantinib s-malate →fda approvals ↗
    ›Oct 22, 2020approval2116d agoVEKLURY (REMDESIVIR) — FDA approvalremdesivir

    Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: INTRAVENOUS

    full page →remdesivir →fda approvals ↗
    ›Oct 23, 2020approval2115d agoXTANDI (ENZALUTAMIDE) — FDA approvalenzalutamide

    Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL

    full page →enzalutamide →fda approvals ↗

    Week of Oct 26, 2020

    13
    ›Oct 27, 2020approval2111d agoAMPHETAMINE SULFATE — FDA approvalamfetamine ER

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →amfetamine ER →fda approvals ↗
    ›Oct 28, 2020approval

    Week of Nov 2, 2020

    7
    ›Nov 3, 2020approval2104d agoELELYSO (TALIGLUCERASE ALFA) — FDA approvaltaliglucerase alfa

    Sponsor: PFIZER. Form: POWDER. Route: INTRAVENOUS

    full page →taliglucerase alfa →fda approvals ↗
    ›Nov 4, 2020approval

    Week of Nov 9, 2020

    15
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval
    ← prev
    page 44 of 579
    next →
    2110d ago
    ALEVE (NAPROXEN SODIUM) — FDA approvalNAPROXEN SODIUM

    Sponsor: BAYER. Form: TABLET. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Oct 28, 2020approval2110d agoACCRUFER (FERRIC MALTOL) — FDA approvalferric maltol

    Sponsor: SHIELD TX. Form: CAPSULE. Route: ORAL

    full page →ferric maltol →fda approvals ↗
    ›Oct 28, 2020approval2110d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Oct 28, 2020approval2110d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Oct 28, 2020approval2110d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Oct 28, 2020approval2110d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Oct 28, 2020approval2110d agoGABAPENTIN — FDA approvalGABAPENTIN

    Sponsor: ZYDUS PHARMS USA INC. Form: TABLET. Route: ORAL

    full page →GABAPENTIN →fda approvals ↗
    ›Oct 29, 2020approval2109d agoBUPROPION HYDROCHLORIDE — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: INVAGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Oct 30, 2020approval2108d agoVALPROIC ACID — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Oct 30, 2020approval2108d agoVALPROIC ACID — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Oct 30, 2020approval2108d agoVALPROIC ACID — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Oct 30, 2020approval2108d agoTRIJARDY XR (EMPAGLIFLOZIN) — FDA approval(empagliflozin + linagliptin + metformin hydrochloride) ER

    Sponsor: BOEHRINGER INGELHEIM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →(empagliflozin + linagliptin + metformin hydrochloride) ER →fda approvals ↗
    2103d ago
    GEMCITABINE HYDROCHLORIDE — FDA approvalGEMCITABINE HYDROCHLORIDE

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →GEMCITABINE HYDROCHLORIDE →fda approvals ↗
    ›Nov 4, 2020approval2103d agoALBUTEROL SULFATE — FDA approvalALBUTEROL SULFATE

    Sponsor: CIPLA. Form: AEROSOL, METERED. Route: INHALATION

    full page →ALBUTEROL SULFATE →fda approvals ↗
    ›Nov 5, 2020approval2102d agoCABOMETYX (CABOZANTINIB S-MALATE) — FDA approvalcabozantinib s-malate

    Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL

    full page →cabozantinib s-malate →fda approvals ↗
    ›Nov 6, 2020approval2101d agoAUBAGIO (TERIFLUNOMIDE) — FDA approvalteriflunomide

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →teriflunomide →fda approvals ↗
    ›Nov 6, 2020approval2101d agoAUBAGIO (TERIFLUNOMIDE) — FDA approvalteriflunomide

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →teriflunomide →fda approvals ↗
    ›Nov 6, 2020approval2101d agoCISATRACURIUM BESYLATE — FDA approvalCISATRACURIUM BESYLATE

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →CISATRACURIUM BESYLATE →fda approvals ↗
    2098d ago
    GLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoGLATOPA (GLATIRAMER ACETATE) — FDA approvalGLATIRAMER ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Nov 9, 2020approval2098d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Nov 9, 2020approval2098d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Nov 9, 2020approval2098d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Nov 9, 2020approval2098d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Nov 9, 2020approval2098d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    $INSM131.10-1.09%
    $AMRX18.14+0.39%
    $AMRX18.14+0.39%
    $AMRX18.14+0.39%
    $AMRX18.14+0.39%
    $AMRX18.14+0.39%
    $ANIP78.25-5.30%
    $ABBV246.04+0.89%
    $GILD133.21+1.80%
    $EXEL54.07+3.58%
    $EXEL54.07+3.58%
    $PFE26.76+2.14%
    $RDY12.22+0.91%
    $ANIP78.25-5.30%
    $RDY12.22+0.91%
    $ANIP78.25-5.30%
    $RDY12.22+0.91%
    $RDY12.22+0.91%
    $RDY12.22+0.91%